Drug Type Small molecule drug |
Synonyms COTI 2 |
Target |
Action stimulants |
Mechanism p53 stimulants(Tumor protein p53 stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC19H22N6S |
InChIKeyUTDAKQMBNSHJJB-UHFFFAOYSA-N |
CAS Registry1039455-84-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Phase 1 | United States | 01 Dec 2015 | |
Endometrial Carcinoma | Phase 1 | United States | 01 Dec 2015 | |
Fallopian Tube Carcinoma | Phase 1 | United States | 01 Dec 2015 | |
Lung Cancer | Phase 1 | United States | 01 Dec 2015 | |
Ovarian Cancer | Phase 1 | United States | 01 Dec 2015 | |
Pancreatic Cancer | Phase 1 | United States | 01 Dec 2015 | |
Peritoneal Neoplasms | Phase 1 | United States | 01 Dec 2015 | |
Squamous Cell Carcinoma of Head and Neck | Phase 1 | United States | 01 Dec 2015 | |
Uterine Cervical Cancer | Phase 1 | United States | 01 Dec 2015 | |
Acute Myeloid Leukemia | Preclinical | United States | - | - |